![]() |
||||||
|
![]() | |
![]() | |
![]() | Expression of this gene in the resistant group across all datasets and cell types |
![]() | Significant ligand-receptor pairs related to this gene (This gene does not contain this module) |
![]() | Known drug resistance mechanisms of this gene (This gene does not contain this module) |
![]() | |
![]() | |
![]() | Acts as a transcription factor (This gene does not contain this module) |
![]() | Acts as a drug target< (This gene does not contain this module) |
Gene: RER1 |
Summary for RER1 |
Gene information | Gene symbol | RER1 | Ensembl ID | ENSG00000157916 |
Entrez ID | 11079 | |
Gene name | retention in endoplasmic reticulum sorting receptor 1 | |
Synonyms | NA | |
Gene type | protein_coding | |
UniProtAcc | NA |
Top |
Dataset with differentially expressed gene: RER1 |
![]() |
Dataset | Source | Tissue | Cancer type level1 | Cancer type level2 | Drug type | Regimen | Timepoint | Cell type | avg_log2FC | p_val_adj |
GSE186960 | Panc1 cell line | Cell line | Pancreatic cancer | Pancreatic ductal adenocarcinoma (PDAC) | Chemotherapy | gemcitabine | NA | Malignant cells | 0.417618 | 1.52e-41 |
GSE163836 | FCIBC02 cell line | Cell line | Breast cancer | Inflammatory breast cancer | Chemotherapy | paclitaxel | NA | Malignant cells | -0.282907 | 1.50e-43 |
GSE153697 | patients | Bone marrow aspirate | Acute lymphoblastic leukemia | Relapsed B-cell acute lymphoblastic leukemia (B-ALL) | Immunotherapy | anti-CD19 CAR-T | NA | Malignant cells | 0.345948 | 3.88e-21 |
GSE189460 | patients | Bone marrow aspirate | Multiple myeloma | Multiple myeloma (MM) | Targeted therapy | bortezomib + melphalan + prednisolone | pre | Malignant cells | 0.29106 | 0.00e+00 |
GSE139386 | H3122 cell line | Cell line | Lung cancer | EML4-ALK fusion-positive non-small cell lung cancer (NSCLC) | Targeted therapy | ceritinib | NA | Malignant cells | 0.258982 | 7.01e-45 |
GSE168668 | LNCaP cell line | Cell line | Prostate cancer | Prostate cancer | Targeted therapy | enzalutamide | NA | Malignant cells | 0.31388 | 0.00e+00 |
GSE199333 | patients | Bone marrow aspirate | Acute myeloid leukemia | Primary FLT3-ITD-mutated acute myeloid leukemia (AML) | Targeted therapy | gilteritinib | post | NK cells | 0.296939 | 1.98e-33 |
GSE199333 | patients | Bone marrow aspirate | Acute myeloid leukemia | Primary FLT3-ITD-mutated acute myeloid leukemia (AML) | Targeted therapy | gilteritinib | post | Malignant cells | 0.33422 | 0.00e+00 |
GSE131984_JQ1 | SUM159 cell line | Cell line | Breast cancer | Triple-negative breast cancer (TNBC) | Targeted therapy | JQ1 | NA | Malignant cells | -0.316684 | 1.58e-23 |
GSE131984_JQ1Pac | SUM159 cell line | Cell line | Breast cancer | Triple-negative breast cancer (TNBC) | Targeted therapy | JQ1 + paclitaxel | NA | Malignant cells | -0.359928 | 5.99e-19 |
GSE131984_JQ1Pal | SUM159 cell line | Cell line | Breast cancer | Triple-negative breast cancer (TNBC) | Targeted therapy | JQ1 + palbociclib | NA | Malignant cells | -0.350257 | 3.55e-25 |
GSE108397 | 451Lu cell line | Cell line | Melanoma | Melanoma | Targeted therapy | PLX-4720 | NA | Malignant cells | -0.755895 | 0.00e+00 |
GSE175716 | PDX | Tumor tissue | Liver cancer | Advanced hepatocellular carcinoma | Targeted therapy | sorafenib | NA | Malignant cells | -0.482684 | 5.24e-42 |
GSE164897_VemCob | A375 cell line | Cell line | Melanoma | BRAFV600E-mutant melanoma | Targeted therapy | vemurafenib + combimetinib | NA | Malignant cells | -0.761584 | 0.00e+00 |
GSE164897_VemTra | A375 cell line | Cell line | Melanoma | B+E2:E57RAFV600E-mutant melanoma | Targeted therapy | vemurafenib + trametinib | NA | Malignant cells | -0.57855 | 0.00e+00 |
Top |
Expression of RER1 in the resistant group across all datasets and cell types |
![]() |
![]() |
Top |
Significant ligand-receptor pairs related to RER1 |
![]() |
Top |
Known drug resistance mechanisms of this gene |
![]() |
Top |
MicroRNAs (miRNA) regulating RER1 |
![]() |
Gene symbol | miRNA | Score | GeneBank accession |
RER1 | hsa-miR-937-5p | 94.6997 | NM_007033 |
RER1 | hsa-miR-424-3p | 93.9453 | NM_007033 |
RER1 | hsa-miR-8081 | 93.1605 | NM_007033 |
RER1 | hsa-miR-3611 | 92.8579 | NM_007033 |
RER1 | hsa-miR-1277-5p | 92.0978 | NM_007033 |
RER1 | hsa-miR-5692b | 91.9111 | NM_007033 |
RER1 | hsa-miR-5692c | 91.9111 | NM_007033 |
RER1 | hsa-miR-5702 | 88.6201 | NM_007033 |
RER1 | hsa-miR-4740-5p | 86.8402 | NM_007033 |
RER1 | hsa-miR-205-3p | 86.5226 | NM_007033 |
RER1 | hsa-miR-181b-3p | 85.3623 | NM_007033 |
RER1 | hsa-miR-181b-2-3p | 85.3623 | NM_007033 |
RER1 | hsa-miR-627-5p | 84.5607 | NM_007033 |
RER1 | hsa-miR-24-3p | 82.9139 | NM_007033 |
RER1 | hsa-miR-6783-3p | 82.8905 | NM_007033 |
RER1 | hsa-miR-5011-5p | 82.389 | NM_007033 |
RER1 | hsa-miR-548an | 81.0384 | NM_007033 |
RER1 | hsa-miR-548u | 80.7018 | NM_007033 |
RER1 | hsa-miR-7161-5p | 80.6768 | NM_007033 |
RER1 | hsa-miR-4799-3p | 80.5028 | NM_007033 |
RER1 | hsa-miR-4720-5p | 80.5028 | NM_007033 |
RER1 | hsa-miR-5588-5p | 80.5028 | NM_007033 |
RER1 | hsa-miR-1269a | 80.2137 | NM_007033 |
RER1 | hsa-miR-1269b | 80.2137 | NM_007033 |
Page: 1 |
Top |
Motifs and transcription factors (TFs) regulating RER1 |
![]() |
Gene symbol | motif | TF_highConf |
RER1 | taipale_tf_pairs__TEAD4_ETV1_RSCGGAAATRCM_CAP | ETV1; TEAD4 (directAnnotation). |
RER1 | taipale_tf_pairs__ETV2_TEF_RSCGGAWNTTRCGYAAN_CAP | ETV2; TEF (directAnnotation). |
RER1 | taipale_tf_pairs__ERF_HES7_NCCGGAANNNNNNCACGYGNN_CAP_repr | ERF; HES7 (directAnnotation). |
RER1 | transfac_pro__M06141 | ZNF708 (directAnnotation). |
RER1 | jaspar__MA1122.1 | TFDP1 (directAnnotation). |
Page: 1 2 |
Top |
Acts as a transcription factor |
![]() |
Top |
Acts as a drug target |
![]() |
1 | "Sun X, Zhang Y, Li H, Zhou Y, Shi S, Chen Z, He X, Zhang H, Li F, Yin J, Mou M, Wang Y, Qiu Y, Zhu F. DRESIS: the first comprehensive landscape of drug resistance information. Nucleic Acids Res. 2023 Jan 6;51(D1):D1263-D1275. doi: 10.1093/nar/gkac812. PMID: 36243960; PMCID: PMC9825618." |
2 | "Wishart DS, Feunang YD, Guo AC, Lo EJ, Marcu A, Grant JR, Sajed T, Johnson D, Li C, Sayeeda Z, Assempour N, Iynkkaran I, Liu Y, Maciejewski A, Gale N, Wilson A, Chin L, Cummings R, Le D, Pon A, Knox C, Wilson M. DrugBank 5.0: a major update to the DrugBank database for 2018. Nucleic Acids Res. 2018 Jan 4;46(D1):D1074-D1082. doi: 10.1093/nar/gkx1037. PMID: 29126136; PMCID: PMC5753335." |